{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:57:23Z","timestamp":1791341843712,"version":"4.3.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:00:00Z","timestamp":1728950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DP2DA053720"],"award-info":[{"award-number":["DP2DA053720"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.josat.2024.209535","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T03:14:27Z","timestamp":1728098067000},"page":"209535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Limited acceptance of buprenorphine in recovery residences in South Florida: A secret shopper survey"],"prefix":"10.1016","volume":"168","author":[{"given":"Madison R.","family":"Guido","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maia H.","family":"Hauschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansel E.","family":"Tookes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler S.","family":"Bartholomew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Edward","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2024.209535_bb0005","author":"Aronberg"},{"key":"10.1016\/j.josat.2024.209535_bb0010","author":"Attorneys at the Legal Action Center"},{"issue":"9","key":"10.1016\/j.josat.2024.209535_bb0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.34540","article-title":"Buprenorphine dose and time to discontinuation among patients with opioid use disorder in the era of fentanyl","volume":"6","author":"Chambers","year":"2023","journal-title":"JAMA Network Open"},{"issue":"12","key":"10.1016\/j.josat.2024.209535_bb0020","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1001\/jamainternmed.2014.5302","article-title":"Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: A randomized clinical trial","volume":"174","author":"Fiellin","year":"2014","journal-title":"JAMA Internal Medicine"},{"key":"10.1016\/j.josat.2024.209535_bb0025","author":"Florida Association of Recovery Residences"},{"key":"10.1016\/j.josat.2024.209535_bb0030","author":"Florida Association of Recovery Residences"},{"key":"10.1016\/j.josat.2024.209535_bb0035","author":"Florida Association of Recovery Residences"},{"key":"10.1016\/j.josat.2024.209535_bb0040","author":"Foundations Recovery Network"},{"key":"10.1016\/j.josat.2024.209535_bb0045","first-page":"1","article-title":"Providers\u2019 attitudes towards buprenorphine and its role in opioid use disorder treatment: An examination of barriers and opportunities","volume":"113","author":"Hadland","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2024.209535_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: Building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"Journal of Biomedical Informatics"},{"issue":"2","key":"10.1016\/j.josat.2024.209535_bb0055","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"Journal of Biomedical Informatics"},{"key":"10.1016\/j.josat.2024.209535_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109504","article-title":"Buprenorphine implementation at syringe service programs following waiver of the Ryan Haight Act in the United States","volume":"237","author":"Lambdin","year":"2022","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2024.209535_bb0065","author":"Lopez"},{"issue":"12","key":"10.1016\/j.josat.2024.209535_bb0070","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1038\/s41380-018-0094-5","article-title":"Effects of medication-assisted treatment on mortality among opioids users: A systematic review and meta-analysis","volume":"24","author":"Ma","year":"2019","journal-title":"Molecular Psychiatry"},{"issue":"Suppl. 3","key":"10.1016\/j.josat.2024.209535_bb0075","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s11606-020-06257-4","article-title":"Barriers and facilitators to the use of medications for opioid use disorder: A rapid review","volume":"35","author":"Mackey","year":"2020","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.josat.2024.209535_bb0080","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.socscimed.2019.05.027","article-title":"Intervention stigma: How medication-assisted treatment marginalizes patients and providers","volume":"232","author":"Madden","year":"2019","journal-title":"Social Science & Medicine"},{"issue":"14","key":"10.1016\/j.josat.2024.209535_bb0085","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1080\/10826084.2021.1975749","article-title":"Intervention stigma toward medications for opioid use disorder: A systematic review","volume":"56","author":"Madden","year":"2021","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.josat.2024.209535_bb0090","first-page":"43","article-title":"Evaluating the effectiveness of addiction treatment: How do we balance the need for standardization with the need for individualized care?","volume":"62","author":"McLellan","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2024.209535_bb0095","author":"Medical Examiners Commission"},{"key":"10.1016\/j.josat.2024.209535_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.109188","article-title":"Identifying the availability of recovery housing in the U.S.: The NSTARR project","volume":"230","author":"Mericle","year":"2022","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2024.209535_bb0105","author":"National Alliance for Recovery Residences"},{"key":"10.1016\/j.josat.2024.209535_bb0110","author":"National Association of Drug Diversion Investigators"},{"key":"10.1016\/j.josat.2024.209535_bb0115","author":"National Institute on Drug Abuse"},{"key":"10.1016\/j.josat.2024.209535_bb0120","author":"National Vital Statistics System"},{"key":"10.1016\/j.josat.2024.209535_bb0125","author":"R Core Team"},{"issue":"3","key":"10.1016\/j.josat.2024.209535_bb0130","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1176\/appi.ps.201300243","article-title":"Recovery housing: Assessing the evidence","volume":"65","author":"Reif","year":"2014","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.josat.2024.209535_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102704","article-title":"\u201cYou are not clean until you\u2019re not on anything\u201d: Perceptions of medication-assisted treatment in rural Appalachia","volume":"85","author":"Richard","year":"2020","journal-title":"The International Journal on Drug Policy"},{"issue":"6","key":"10.1016\/j.josat.2024.209535_bb0140","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s40263-019-00637-z","article-title":"Buprenorphine treatment for opioid use disorder: An overview","volume":"33","author":"Shulman","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.josat.2024.209535_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108900","article-title":"Not in my treatment center: Leadership\u2019s perception of barriers to MOUD adoption","volume":"144","author":"Stewart","year":"2023","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2024.209535_bb0150","author":"Substance Abuse and Mental Health Services Administration"},{"key":"10.1016\/j.josat.2024.209535_bb0155","author":"Substance Abuse and Mental Health Services Administration"},{"key":"10.1016\/j.josat.2024.209535_bb0160","author":"Substance Abuse and Mental Health Services Administration"},{"key":"10.1016\/j.josat.2024.209535_bb0165","author":"U.S. Department of Housing and Urban Development"},{"key":"10.1016\/j.josat.2024.209535_bb0170","author":"U.S. Department of Justice Civil Rights Division"},{"key":"10.1016\/j.josat.2024.209535_bb0175","author":"U.S. Department of Justice Civil Rights Division"},{"key":"10.1016\/j.josat.2024.209535_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108747","article-title":"Acceptance of medications for opioid use disorder in recovery housing programs in Missouri","volume":"138","author":"Wood","year":"2022","journal-title":"Journal of Substance Abuse Treatment"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875924002479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875924002479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T06:18:51Z","timestamp":1733293131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875924002479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":36,"alternative-id":["S2949875924002479"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2024.209535","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Limited acceptance of buprenorphine in recovery residences in South Florida: A secret shopper survey","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2024.209535","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"209535"}}